SPECIMEN SAMPLING

February 3, 2007
Dr. Ramazi Mitaishvili

Dr. Ramazi Mitaishvili

Ramaz Mitaishvili, MD

Private Practice of Pediatric
Global Health University of Southern California

Glendale, CA

 

 

 

 

CAPILLARY BLOOD GAS SAMPLING FOR

NEONATAL & PEDIATRIC PATIENTS

1. PROCEDURE:
Capillary sampling for blood gas analysis

2. DESCRIPTION:
Capillary blood gas (CBG) samples may be used in place of

samples from arterial punctures or indwelling arterial catheters to estimate

acid-base balance (pH) and adequacy of ventilation (PaCO2). Capillary PO2 measurements are of little value in estimating arterial oxygenation.

A puncture or small incision is made with a lancet or similardevice into the cutaneous layer of the skin at a highly

vascularized area (heel, finger, toe). (The lancet may be used freehand or

as part of a device that limits puncture depth.) To accelerate blood flow and

reduce the difference between the arterial and venous gas pressures, the area

is warmed prior to the puncture. As the blood flows freely from the puncture site,

the sample is collected in a heparinized glass capillary tube.

3. SETTING:
Capillary sampling may be performed by trained health care personnel in
A. Acute care hospitals,
B. Clinics,
C. Physician offices,
D. Extended care facilities,
E. Homes.



4. INDICATIONS:
Capillary blood gas sampling is indicated when
A. Arterial blood gas analysis is indicated but arterial access is
not available.
B. Noninvasive monitor readings are abnormal: transcutaneous values,
end-tidal

CO2, pulse oximetry.
C. Assessment of initiation, administration, or change in
therapeutic modalities

(i.e., mechanical ventilation) is indicated.
D. A change in patient status is detected by history or physical assessment.
E. Monitoring the severity and progression of a documented
disease

process is desirable.

5. CONTRAINDICATIONS:
A. Capillary punctures should not be performed
– at or through the following sites;
– posterior curvature of the heel, as the device may puncture
the bone;
– the heel of a patient who has begun walking and has callus development;
– the fingers of neonates (to avoid nerve damage);
– previous puncture sites;
– inflamed, swollen, or edematous tissues;
– cyanotic or poorly perfused tissues;
– localized areas of infection;
– peripheral arteries.
– on patients less than 24 hours old, due to poor peripheral perfusion;
– when there is need for direct analysis of oxygenation;
– when there is need for direct analysis of arterial blood;
B. Relative contraindications include
– peripheral vasoconstriction;
– polycythemia (due to shorter clotting times);
– hypotension may be a relative contraindication.

6. HAZARDS/COMPLICATIONS:
A. Infection
– Introduction of contagion at sampling site and consequent infection

in patient, including calcaneus osteomyelitis and cellulitis
– Inadvertent puncture or incision and consequent infection in sampler
B. Burns
C. Hematoma
D. Bone calcification
E. Nerve damage
F. Bruising
G. Scarring
H. Puncture of posterior medial aspect of heel may result in

tibial artery laceration
I. Pain
J. Bleeding
K. Inappropriate patient management may result from reliance on capillary

PO2 values.

7. LIMITATIONS OF METHOD/ VALIDATION OF RESULTS:
A. Limitations
– Inadequate warming of the site prior to a puncture may result in capillary

values that correlate poorly with arterial pH and PCO2 values.
– Undue squeezing of the puncture site may result in venous
and

lymphatic contamination of the sample.
– A second puncture may be needed to obtain an adequate
amount

of blood for analysis.
– Variability in capillary PO2 values precludes using these
samples

for assessing oxygenation status.
B. Validation of results
– Sample must be anticoagulated and obtained anaerobically
with capillary

tube filled completely and air bubbles expelled immediately. Sample should

be immediately chilled or analyzed within 10-15 minutes if left at room

temperature.
– A respiratory assessment of the patient should be
documented in the

medical record at the time a capillary sample is performed
– An arterial sample may be analyzed to compare with the capillary
pH and

PCO2 values.

8. ASSESSMENT OF NEED:
Capillary blood gas sampling is an intermittent procedure and should be

performed when a documented need exists. Routine or standing orders

for capillary puncture are not recommended. The following may assist

the clinician in assessing the need for capillary blood gas sampling:
A. History and physical assessment;
B. Noninvasive respiratory monitoring values
– Pulse oximetry;
– Transcutaneous values;
– End-tidal CO2 values;
C. Patient response to initiation, administration, or change in therapeutic

modalities;
D. Lack of arterial access for blood gas sampling.

9. ASSESSMENT OF TEST QUALITY:
Sampling of capillary blood is useful for patient management only if the

procedure is carried out according to an established quality assurance

program. The validity of the test may be jeopardized if any of the following occur:
A. The sample is contaminated by air;
B. Clots prevent accurate analysis;
C. Quantity of sample is insufficient for analysis;
D. Analysis of sample is delayed (> 15 minutes for samples at
room temperature,

or > 60 minutes for samples held at 4°C).

10. RESOURCES:
A. Equipment: Single puncture-preheparinized glass capillary (eg, Natelson)

tubes, metal fleas, magnet, clay/wax sealant or caps, lancet to make

incision < 2.5 mm in depth, gauze/cotton balls, ice, gloves, skin antiseptic,

warm and moist cloth/diaper or commercially prepared warming pads (42°C),

sharps container, labeling materials
B. Personnel: Capillary sampling must be performed under
direction of a

physician. Individuals who perform capillary sampling should have a

background in mathematics and science and specific training in capillary

blood sampling and related procedures. They must competently demonstrate

capillary blood gas sampling and undergo periodic skills assessment of

technique: implementation of Universal Precautions; success at obtaining

a quality sample; preparation, storage and transport of specimens;

documentation; and post sampling site care and/or complication rate.

11. MONITORING:
The following should be monitored and documented in the medical record

as part of the capillary sampling procedure:
A. FIO2 or prescribed oxygen flow;
B. Oxygen administration device or ventilator settings;
C. Free flow of blood without the necessity for `milking' the
foot or finger

to obtain a sample;
D. Presence/absence of air or clot in sample;
E. Patient temperature, respiratory rate, position or level of
activity,

and clinical appearance;
F. Ease or difficulty of obtaining sample;
G. Appearance of puncture site;
H. Complications or adverse reactions to the procedure;
I. Date, time, and sampling site;
J. Noninvasive monitoring values: transcutaneous O2 & CO2,
end-tidal

CO2, and/or pulse oximetry;
K. Results of the blood gas analysis.

12. FREQUENCY:
The frequency of capillary sampling should depend upon the clinical status

of the patient and the indications for performing the procedure, not upon

a prescribed frequency.
A. Those patients requiring frequent CBGs should be
considered candidates

for placement of an indwelling arterial access for blood gas sampling or

noninvasive monitoring techniques, to limit trauma associated with repeated

punctures.
B. Repeated puncture of the foot/finger increases the risk of
scarring or

serious laceration. Care should be exercised to alternate the sampling site

for patients requiring multiple punctures.

13. INFECTION CONTROL:
A. Universal Precautions as published by the Centers for
Disease Control

and directives issued by the Department of Labor concerning occupational

exposure to blood-borne pathogens must be followed during capillary sampling.
B. Aseptic techniques should be employed due to the invasive
nature of

this procedure. Punc-ture site should be cleaned with antiseptic solution.
C. Blood specimens, contaminated materials, and lancets must
be disposed

of in appropriate containers.
D. Gloves should be worn by caregivers to protect against
blood splashes on

sores or skin breaks.

http://www.rmgh.net/index.php?option=com_content&task=view&id=68&Itemid=2

Continue Reading

Allen Test

Opioid Drugs

RMGH NEWSLETTER

RMGH NEWSLETTER

QT NEWSLETTER

RMGH NEWSLETTER

ASA NEWSLETTER

RMGH NEWSLETTER

ASA NEWSLETTER

ASA NEWSLETTER

ASA NEWSLETTER

FDA ALERT

FDA ALERT

FDA ALERT

FDA ALERT

FDA ALERT

SPECIMEN SAMPLING

SPECIMEN SAMPLING

Popular Courses